User talk:Boghog

From Wikipedia, the free encyclopedia
  (Redirected from User talk:BogBot)
Jump to: navigation, search

Variability in PSA Measurement[edit]

I have edited it just because it is a very common problem occuring in practice. The review artcile may not be upto date but it is addressed considering routine problem of clinicains and lab professionals.

ERCC6[edit]

Hello Boghog,

I just want to let you know I will be editing the ERCC6 page quite a bit in the next few days. I will make sure not to amend any of the content you have written.

I am a Stanford University junior majoring in chemical engineering; the reason for my edits of this page stem from a project I am doing for biochemistry 2 class here (ChemE183). As part of my grade, my edits must be able to be seen (obviously). I just wanted to let you know, and ask that if I put any information on the page/formatting that you don't agree with, please let me know and I will fix it immediately. I don't want to step on the shoes of any other editors; yet, I also want to make sure my content that I am taking quite a bit of time to post doesn't get deleted.

Thanks so much and let me know if any other concerns arise.

Ajit Vakharia Stanford '16 — Preceding unsigned comment added by Ajit Vakharia (talkcontribs) 23:38, 2 March 2015 (UTC)

I appreciate this.[edit]

Useless generalization deleted. I am sure that you have become aware that sulfur in cysteine is quite different from that in ITC, so that the change was also an implausible generalization. In other words, the change was about sulfur-containing phytochemicals, about which nobody can make useful generalizations in effect on life, and the article is restricted to about three specific categories. Thanks. 70.74.198.226 (talk) 09:40, 3 March 2015 (UTC)

Disambiguation link notification for March 7[edit]

Hi. Thank you for your recent edits. Wikipedia appreciates your help. We noticed though that when you edited MTA1, you added a link pointing to the disambiguation page Transcription (check to confirm | fix with Dab solver). Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ • Join us at the DPL WikiProject.

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 09:19, 7 March 2015 (UTC)

TFA blurb[edit]

Hey Boghog, as you probably already know from the edit notification/echo ping, I've nominated the amphetamine article for TFA. I was wondering what you thought about the blurb I wrote for it at Wikipedia:Today's featured article/requests/Amphetamine. I basically just took a couple sentences from the first 2 lead paragraphs and condensed them to meet the ~1,200 character limit (I just made sure it had fewer characters than the featured article blurb for today, which is over 1,200).

Is there anything you think we should change in it? Seppi333 (Insert  | Maintained) 03:49, 9 March 2015 (UTC)

@Seppi333: Thanks for nominating the article and including me as a coconspirator ;-) Looking over the blurb, I think it could be simplified a bit and reorganized to place first what most people are interested in, namely its use. Below is a suggestion. Cheers Boghog (talk) 20:55, 9 March 2015 (UTC)
Amphetamine is a potent central nervous system stimulant of the phenethylamine class that is used in the treatment of attention deficit hyperactivity disorder and narcolepsy. It is also used as a performance enhancer and nootropic, and recreationally as an aphrodisiac and euphoriant. Amphetamine increases neurotransmitter activity in the brain, with its most pronounced effects on norepinephrine and dopamine. At therapeutic doses, this causes emotional and cognitive effects such as euphoria, change in libido, increased wakefulness, and improved cognitive control. It induces physical effects such as decreased reaction time, fatigue resistance, and increased muscle strength. Amphetamine exists as two enantiomers, levoamphetamine and dextroamphetamine, and normally refers to a 1:1 mixture of the two enantiomers in its free base form. It is a prescription medication in many countries, and unauthorized possession and distribution of amphetamine is often tightly controlled due to the significant health risks associated with uncontrolled or heavy use.
I've updated it per your suggestion, though I made a small revision to the 1:1 mixture clause since I'm not sure if the average reader will realize it's referring to a ratio vs something else. Since it was below the word limit, I just rewrote that part as "and normally refers to an equal parts mixture of the two enantiomers in its free base form." Regards, Seppi333 (Insert  | Maintained) 21:15, 9 March 2015 (UTC)

Reference Errors on 11 March[edit]

Hello, I'm ReferenceBot. I have automatically detected that an edit performed by you may have introduced errors in referencing. It is as follows:

Please check this page and fix the errors highlighted. If you think this is a false positive, you can report it to my operator. Thanks, ReferenceBot (talk) 00:24, 12 March 2015 (UTC)

Disambiguation link notification for March 16[edit]

Hi. Thank you for your recent edits. Wikipedia appreciates your help. We noticed though that you've added some links pointing to disambiguation pages. Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ • Join us at the DPL WikiProject.

Lysophosphatidic acid phosphatase type 6 (check to confirm | fix with Dab solver)
added a link pointing to Asp
PDE6B (check to confirm | fix with Dab solver)
added a link pointing to Photoreceptor

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 09:25, 16 March 2015 (UTC)

hi[edit]

Boghog you have a minute--Ozzie10aaaa (talk) 19:31, 19 March 2015 (UTC)

@Ozzie10aaaa: Hi. I do have a minute. For ? Boghog (talk) 19:34, 19 March 2015 (UTC)
Boghog...a week ago Bluerasberry approved #3 criteria for Dyslexia for GA nomination however he told me I needed someone else to finish and close, interested?--Ozzie10aaaa (talk) 19:38, 19 March 2015 (UTC)
Hmm, this is a bit outside my area of expertise. But I will take a look at this over the weekend to provide my opinion if the missing recommended MEDMOS content is required or not. Cheers. Boghog (talk) 19:45, 19 March 2015 (UTC)
ok...thanks--Ozzie10aaaa (talk) 19:47, 19 March 2015 (UTC)

Disambiguation link notification for March 23[edit]

Hi. Thank you for your recent edits. Wikipedia appreciates your help. We noticed though that when you edited DNAJC19, you added a link pointing to the disambiguation page Chaperone (check to confirm | fix with Dab solver). Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ • Join us at the DPL WikiProject.

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 08:54, 23 March 2015 (UTC)

ERCC4 entry[edit]

Hello Boghog - thank you for your guidelines on formatting this page. I will be working on this entry and that for ERCC1 under the direction of Andrew Su and Ginger Tsueng of the journal GENE (Elsevier Press) who have asked us to edit this entry in addition to writing a review article on ERCC1 and ERCC4 that will be published in GENE. HumDNARepair (talk) 21:20, 24 March 2015 (UTC)

Thanks for excellent contributions! I hope you don't mind, but I changed back the protein name to ERCC-4 (the recommended alternate UniProt name, see Q92889) while leaving the ERCC4 gene symbol (the approved HUGO gene symbol). Gene and protein names often differ. Boghog (talk) 21:32, 24 March 2015 (UTC)